Transcript Bovie Medical


This presentation may contain some forward looking
statements, particularly regarding operational
prospects in 2008 and beyond, which involve a
number of risks and uncertainties that could cause
actual results to differ materially. These risks are
listed from time to time in the Company’s SEC filings.
BOVIE = ELECTROSURGERY



Surgical instruments in the OR that are
related to electrosurgery are called by
the name “BOVIE.”
Branding the “Bovie” name within the
medical community
Over 32 million surgical procedures in
U.S.
Bovie Medical
MEG Line
Instruments
Icon GS
Plasma
ICON
Generators
Bovie
Electrosurgery
Tissue
Resection
Canaday
Accessories
ICON
GP/VS
High & Low Temperature Cauteries




Targeted towards the
Gastroenterology market.
Over $150 million market
including accessories growing 79% per year
13,000 operating centers
Icon platform provides the basis
to develop customized
generators for other specialties
(ex. Oncology $200 million).
MEG line of instruments
MEG/Polaris™ Instruments


The only product that can compete in three
markets and address all areas of minimally
invasive surgeries:
Arthroscopy Instrument Market $200 million
Laparoscopy Instrument Market $300 million
Vessel Sealing Market $500 million
Arthroscopy Instrument





Market research indicates little to no
innovation from top five companies in
this space over the past 15 years.
The only modular arthroscopy
instrument available.
Can dramatically reduce cost to the
end user.
The only arthroscopy instrument with
a flushing port for cleaning.
One tip design can replace multiple
instruments.
Laparoscopy Instrument





Handle accepts inserts from 2mm
to 12mm
Cancelable ratchet feature can be
activated either left or right
handed.
Ergonomic handle reduces fatigue
and creates more leverage.
Modular design can significantly
reduce cost
Metallic handle is electrically
isolated to increase instrument life.
Vessel Sealing Instrument






Only modular designed laparoscopic VS instrument
Handle can accommodate both “open” and laparoscopic
instrument tips.
“Seal and Cut” design.
Can be used with existing vessel sealing generators or
user can gain enhanced benefits with Bovie generator.
Significantly reduces costs.
Largest (total market size $500 million) and fastest
growing (10-15%) segment with highest margins.
•Ergonomic
•360 Rotation of cartridge
•Electrode quick attachmentdetachment
•Can be controlled by three
triggers:
Jaw trigger
Coagulation + sealing
trigger
Powered blade trigger
Handle & Bovie VS generator
provides:
•Cartridge recognition and initial
setup
•Automatic bipolar cut upon
blade advancement
•Modulated vessel sealing
automatic cycles
•Minimal charring and adhesion
Suitable for a variety of endoscopic Bipolar AND
Monopolar or Inert applications like
Vessel Sealing
Laparoscopy
Endo GYN
Arthroscopy
Urology
Thoracic Endoscopy
Sinoscopy
and many other open surgery adaptations
Tissue Resection Device





Delivers RF current & sterile saline for resection,
hemostatic sealing and coagulation
Lowers blood loss, procedure times and cost savings
for hospitals
Liver, pancreatic, kidney tumor removal
Orthopedic and laparoscopic surgeries
Worldwide market size in 2009 approx. $500 million
ICON GS Plasma System

J-Plasma is formed by holding a sharp
conductive point at High Voltage and High
Frequency, over which an Inert Gas, such as
Helium, flows.
ICON GS Plasma System




Produces a stable thin focused beam of
ionized helium gas
Provides minimal invasiveness and
precision
No conductive currents during surgery
One working electrode
Canady Technology Agreements



Worldwide distribution and manufacturing agreement
for Canady’s plasma related devices and accessories.
Canady Technology will assist in the clinical
development of Bovie’s J-Plasma technology.
Canady Technology was the first to demonstrate the
utilization of tissue coagulation by argon plasma
coagulation via flexible endoscopes.
Bovie Medical Financials
Amex Symbol: BVX
 Fiscal year 2007 revenues rose to a
record $28.78 million.
 Net income for fiscal 2007 was
$2,400,591 or $.14 per diluted EPS.
 17,600,000 diluted shares outstanding.
 10% insider ownership.
Contact Information
Bovie Medical, Inc.
Suite 207, 734 Walt Whitman Road
Melville, NY 11747
800-888-4999
[email protected]
Buttonwood Advisory Group, Inc.
15705 Framingham Lane
Huntersville, NC 28078
800-940-9087
[email protected]